Centric Health Corp. (TSE:CRX – Free Report) – Equities research analysts at Ventum Cap Mkts decreased their FY2024 earnings per share (EPS) estimates for shares of Centric Health in a note issued to investors on Monday, November 11th. Ventum Cap Mkts analyst S. Quenneville now expects that the company will earn ($0.05) per share for the year, down from their previous forecast of ($0.04). Ventum Cap Mkts has a “Strong-Buy” rating on the stock.
Separately, Stifel Canada cut Centric Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 12th.
Centric Health Stock Performance
Read More
- Five stocks we like better than Centric Health
- How to Read Stock Charts for Beginners
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- Dividend Capture Strategy: What You Need to Know
- Tariff Troubles: 3 Stocks Planning Higher Prices
- Investing in the High PE Growth Stocks
- Mercer Near Rock Bottom: Is This High-Yield Play Set to Soar?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
